Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,439.00
Bid: 4,438.00
Ask: 4,439.00
Change: 24.00 (0.54%)
Spread: 1.00 (0.023%)
Open: 4,416.00
High: 4,440.00
Low: 4,410.00
Prev. Close: 4,415.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share purchase programme management share scheme

29 Apr 2019 10:00

RNS Number : 3870X
Unilever PLC
29 April 2019
 

 

Share purchase programme for management share scheme

 

29th April 2019

 

London/Rotterdam - The Unilever Group today announces a programme to purchase shares up to an aggregate market value equivalent of €165 million. The purpose of the programme is to enable the Group to meet share award obligations under its Management Co-Investment Plan. The programme, to be conducted by Unilever N.V., will commence on 29th April 2019 and will end no later than close of business on 17th May 2019.

 

Under the terms of the programme, a maximum of 995,000 Unilever PLC ordinary shares and 1,787,000 Unilever N.V. ordinary shares (or depositary receipts in respect of such ordinary shares) will be purchased.

 

The share purchase programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052.

The Group has entered into non-discretionary instructions with UBS AG London Branch to conduct the share purchase programme on its behalf and to make trading decisions under the programme independently of the Group.

 

In addition, up to 81,000 American Depositary Shares of Unilever PLC and up to 891,000 New York Registry Shares of Unilever N.V. will be repurchased for the same purpose on the New York Stock Exchange based on non-discretionary instructions with UBS Securities LLC.

 

Media enquiries

Media Relations UK: +44 7934 483 444 

Media Relations Netherlands: +31 10 217 4844

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

Unilever PLC

 

100 Victoria Embankment

London

EC4Y 0DY

United Kingdom

 

+44 (0) 207 822 5252

Press-Office.London@Unilever.com

 

Unilever NV

 

Weena 455

3013AL

Rotterdam

www.unilever.nl

 

+31 (0) 10 217 4000

mediarelations.rotterdam@Unilever.com

 

 

Safe Harbour

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will' or the negative of this term and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the "Group"). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCILMPTMBATMFL
Date   Source Headline
10th Sep 20194:02 pmRNSDirector/PDMR Shareholding
6th Sep 20193:02 pmRNSDirector/PDMR Shareholding
3rd Sep 20199:00 amRNSPassing away of Independent Non-Executive Director
12th Aug 20193:36 pmRNSDirector/PDMR Shareholding
5th Aug 20194:45 pmRNSDirector Declaration
25th Jul 20197:00 amRNS2019 First Half Year Results
9th Jul 20195:04 pmRNSDirector/PDMR Shareholding
27th Jun 20197:00 amRNSUnilever NV Depositary Receipt Structure
12th Jun 20194:14 pmRNSDirector/PDMR Shareholding
7th Jun 20195:16 pmRNSDirector/PDMR Shareholding
7th Jun 20191:11 pmRNSPUBLICATION OF FINAL TERMS: UNILEVER BONDS
4th Jun 20195:50 pmRNSUnilever prices Bonds on European Markets
13th May 201912:25 pmRNSUnilever completes share purchase programme
10th May 20194:10 pmRNSDirector/PDMR Shareholding
9th May 201911:36 amRNSDirector Declaration
3rd May 20193:58 pmRNSDirector Declaration
2nd May 20195:13 pmRNSTransaction in Own Shares
2nd May 20193:40 pmRNSVoting Rights and Capital Update
2nd May 20193:14 pmRNSDirector/PDMR Shareholding
2nd May 20192:30 pmRNSMembership of Board Committees
2nd May 20192:06 pmRNSAGM Statement
1st May 20194:55 pmRNSTransaction in Own Shares
1st May 20197:00 amRNSUnilever Depositary receipt structure
30th Apr 20195:13 pmRNSTransaction in Own Shares
29th Apr 20195:12 pmRNSTransaction in Own Shares
29th Apr 201910:00 amRNSShare purchase programme management share scheme
26th Apr 20195:48 pmRNSDirector/PDMR Shareholding
26th Apr 20194:02 pmRNSDirector Declaration
18th Apr 20197:00 amRNS1st Quarter 2019 Trading Statement
12th Apr 20192:58 pmRNSDirector/PDMR Shareholding
10th Apr 20193:13 pmRNSCancellation of Treasury Shares
10th Apr 201911:42 amRNSDirector/PDMR Shareholding
25th Mar 20194:44 pmRNSDirector/PDMR Shareholding
22nd Mar 201912:18 pmRNSDirector/PDMR Shareholding
20th Mar 201910:07 amRNSNotice of AGM
19th Mar 20195:05 pmRNSDirector/PDMR Shareholding
13th Mar 20195:35 pmRNSDirector/PDMR Shareholding
12th Mar 20192:36 pmRNSDirector/PDMR Shareholding
11th Mar 20195:30 pmRNSAnnual Financial Report
6th Mar 20192:00 pmRNSAGM re-elections and changes to the Boards
14th Feb 20194:49 pmRNSDirector/PDMR Shareholding
13th Feb 20193:37 pmRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSFinal Results
11th Jan 201911:56 amRNSDirector/PDMR Shareholding
11th Dec 20184:42 pmRNSDirector/PDMR Shareholding
10th Dec 20185:20 pmRNSDirector/PDMR Shareholding
3rd Dec 201812:53 pmRNSVoting Rights and Capital Update
3rd Dec 20188:30 amRNSUNILEVER TO ACQUIRE HORLICKS AND OTHER PRODUCTS
30th Nov 20184:56 pmRNSUNILEVER COMPLETES SHARE BUYBACK PROGRAMME
30th Nov 20184:45 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.